
Canada's TD Bank's fourth-quarter profit falls on higher provisions
TD Bank Group reported a fall in its fourth-quarter profit on Thursday, as Canada's second-largest lender set aside
1970-01-01 08:00

From space fascination to romantic birthday gesture: Jeff Bezos' high school sweetheart Ursula Werner opens up about dating Amazon founder
Jeff Bezos and his high school sweetheart, Ursula Werner, who described him as 'wicked and smart', kept in touch over the years
1970-01-01 08:00

Ault Alliance Announces that Its Indirect Subsidiary, MTIX, Ltd. Provides Substantial Cost Savings and Environmental Benefits From Using Its Proprietary MLSE Process
LAS VEGAS--(BUSINESS WIRE)--Nov 30, 2023--
1970-01-01 08:00

Cazoo Announces Expected Record Date for Distribution of Warrants and Expected Effective Date for Reverse Stock Split
LONDON & NEW YORK--(BUSINESS WIRE)--Nov 30, 2023--
1970-01-01 08:00

BJ’s One® Mastercard® Cardholders Can Earn Double Rewards During Special Event
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Nov 30, 2023--
1970-01-01 08:00

NYC Mayor’s Woes Are So Bad Even Andrew Cuomo Is Eyeing a Run
There’s political blood in the water after a series of blows to New York City Mayor Eric Adams,
1970-01-01 08:00

Pioneering drug designed to extend the lives of dogs just made a breakthrough
Our canine companions could soon be enjoying much longer lifespans, if a drug which claims it can extend dogs’ lives eventually gets approved. The drug, made by a tech firm in California, just cleared a vital hurdle to doing just that, after it got partial approval by regulators in the US. Loyal, a San Francisco-based company founded in 2020, has been researching how it can increase dogs’ lifespans – in particular larger breeds, which tend to die younger. Large and “giant” breeds tend to live to between eight and 12 years. Smaller dogs, such as Chihuahuas, can keep going to the ripe old age of 20. Loyal’s main product, the catchily-titled LOY-001, is designed not only to extend dogs’ lives but also maintain their quality of life. Now, it has passed the “reasonable expectation of effectiveness” test, set by regulators at the US’ Food and Drug Administration. Loyal’s chief executive, Celine Halioua, said: "Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs. "This milestone is the result of years of careful work by the team. We'll continue to work just as diligently to bring this and our other longevity programs through to FDA approval." Selective breeding of dogs has caused higher levels of hormones which help the animals grow faster. That is also believed to reduce their lifespan, the company said. Big dogs tend to have more of this hormone than their smaller counterparts. Animal rights activists are not yet convinced. Some experts fear it will only serve to extend animals’ suffering. Loyal, on the other hand, says the drug aims to treat doggy diseases which are associated with ageing through preventing them, rather than waiting for the animals to get sick before treating them. The company said that the drug could be available to US customers as early as 2026. So that’s plenty of time for walkies between now and then. How to join the indy100's free WhatsApp channel Sign up to our free indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.
1970-01-01 08:00

Wall St futures edge higher on easing inflation hopes
U.S. stock index futures edged higher on Thursday, ahead of a reading later in the day that is
1970-01-01 08:00

A Pakistani province aims to deport 10,000 Afghans a day
Authorities in a Pakistani province are setting targets for police to arrest and deport hundreds of thousands of Afghans who are in the country illegally
1970-01-01 08:00

Europe Needs More LNG to Ease Tight Market, Uniper CEO Says
Europe needs more liquefied natural gas to provide relief to its market as the region recovers from last
1970-01-01 08:00

Russell Peters backs Joe Rogan’s definition of ‘cancel culture’: ‘They tried to peg him as a racist'
Joe Rogan has been under constant scrutiny due to his opinions about cancel culture
1970-01-01 08:00

Premier League confirms November Player of the Month nominees
The Premier League confirms its nominees for 2023 November Player of the Month.
1970-01-01 08:00